Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal.Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a publicly…
Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II

























